Engineered stem cells by emerging biomedical stratagems
Science Bulletin · 2024-01 · 69 (2) · 248-279
DOI: 10.1016/j.scib.2023.12.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Bulletin, 2024-01. Verfasst von Jinglin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China; Divisi…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 264 Literaturangaben. Gefördert von: Nanjing University, Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Stem cell therapy holds immense potential as a viable treatment for a widespread range of intractable disorders. As the safety of stem cell transplantation having been demonstrated in numerous clinical trials, various kinds of stem cells are currently utilized in medical applications. Despite the achievements, the therapeutic benefits of stem cells for diseases are limited, and the data of clinical researches are unstable. To optimize tthe effectiveness of stem cells, engineering approaches have been developed to enhance their inherent abilities and impart them with new functionalities, paving the way for the next generation of stem cell therapies. This review offers a detailed analysis of engineered stem cells, including their clinical applications and potential for future development. We begin by briefly introducing the recent advances in the production of stem cells (induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs)). Furthermore, we present the latest developments of engineered strategies in stem cells, including engineered methods in molecular biology and biomaterial fields, and their application in biomedical research. Finally, we summarize the current obstacles and suggest future prospects for engineered stem cells in clinical translations and biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China; Division of Hepatobiliary Surgery and Transplantation Surgery, Department of…
- Division of Hepatobiliary Surgery and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, Chin…
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China. Electronic address: zhouminnju@nju.edu.cn.
Förderung
- Nanjing University
- Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Zhang, X., Chen, H., Ren, H., Zhou, M., & Zhao, Y. (2024). Engineered stem cells by emerging biomedical stratagems. Science Bulletin, 69(2), 248-279. https://doi.org/10.1016/j.scib.2023.12.006
Vancouver
Wang J, Zhang X, Chen H, Ren H, Zhou M, Zhao Y. Engineered stem cells by emerging biomedical stratagems. Science Bulletin. 2024;69(2):248-279. doi:10.1016/j.scib.2023.12.006
BibTeX
@article{Wang2024,
author = {Wang, Jinglin and Zhang, Xiaoxuan and Chen, Hanxu and Ren, Haozhen and Zhou, Min and Zhao, Yuanjin},
title = {Engineered stem cells by emerging biomedical stratagems},
journal = {Science Bulletin},
year = {2024},
volume = {69},
number = {2},
pages = {248--279},
doi = {10.1016/j.scib.2023.12.006}
}
EUVIMED